Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 20, 2023 08:30 ET | Source: Kriya Therapeutics, Inc.

Kriya to Present at the J.P. Morgan 42nd Annual Healthcare Conference

PALO ALTO, Calif., and RESEARCH TRIANGLE PARK, N.C., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Kriya Therapeutics, Inc. ("Kriya"), a biopharmaceutical company developing gene therapies to address common...
September 27, 2023 08:30 ET | Source: Kriya Therapeutics, Inc.

Kriya Announces Exclusive License and Collaboration Agreement with Everads to Advance Gene Therapies for Prevalent Diseases in Ophthalmology Including Geographic Atrophy

– Everads' next generation suprachoroidal delivery technology enables targeted drug delivery to the retina, which Kriya intends to use for multiple ophthalmology gene therapy product candidates – ...
September 06, 2023 08:30 ET | Source: Kriya Therapeutics, Inc.

Kriya Acquires Tramontane Therapeutics and Launches Gene Therapy Program for Nonalcoholic Steatohepatitis (NASH) and Other Prevalent Diseases

– Kriya envisions treating people with NASH using a one-time intramuscular gene therapy enabling continuous expression of native FGF21 – – Kriya anticipates advancing its NASH gene therapy candidate...
July 26, 2023 08:25 ET | Source: Kriya Therapeutics, Inc.

Kriya Announces $150 Million Addition to its Series C, Bringing Total Round to over $430 Million to Further its Mission of Delivering Gene Therapies for Prevalent Diseases

– Kriya's therapeutic pipeline addresses a broad range of diseases that collectively affect millions of patients worldwide—with a goal of delivering transformational clinical benefits with one-time...

keyboard_arrow_left Previous Page